Doctronic and Simple HealthKit collaborate to link AI-powered clinical treatment with at-home screening

AI startup Doctronic is collaborating with Simple HealthKit, an at-home health screening platform, to provide end-to-end diagnostic screening along with virtual clinical care to consumers.

Simple HealthKit offers a health testing service that lets consumers privately gather samples (e.g., blood, urine, or saliva) without the need for a visit to a lab or health clinic, and then send them to a certified laboratory for analysis. The company has an expanding portfolio of at-home screening programs for diabetes, chronic kidney disease, colorectal cancer, cervical cancer, sexually transmitted infections, and other preventable health conditions.

Simple HealthKit sells at-home screening kits directly to the public via its website and retail partners, and also has a health plan partnership program, as well as a provider and public health program partnership program.

As a result of this partnership [with Doctronic] we are initially targeting the conditions where we can make the biggest, most direct impact within our national health plan and our retail partnerships; we are looking at rolling this out more widely across our portfolio in due course. Our vision is to make high-quality healthcare accessible for all,” said Simple HealthKit co-founder and CEO Sheena Menezes.

Doctronic touts that it’s the first AI system legally authorized to practice medicine in the U.S. The startup has a free, personal AI doctor through a chatbot to help you with symptoms and answer medical questions, and a virtual appointment with a licensed doctor. Doctronic, which is sold in all 50 states, is being used now as part of a pilot program in the state of Utah for replacing prescriptions.

Doctronic’s co-CEO and co-founder Adam Oskowitz, explained in an email that patients will first be buying the Simple HealthKit test, before they then get directed to Doctronic after the test results. Once they get there, the AI will know the test results and be able to help the patient go through the medical evaluation based on those results,” Oskowitz said.

After the results of the screening test, patients are referred back to Doctronic for timely clinical follow-up. This equates to an AI-driven, closed-loop care experience, with clinical control and collective intelligence, and patient-centric, according to both companies.

Soon, too, we will be sending patients who are at risk for testing at-home to Simple HealthKit, but that will be a quick follow-up, he said.

With Doctronic, a patient receives a result and can ask questions to an AI health assistant, as well as have a full consultation with a real doctor for treatment. That’s what we’re building together, and we promise it will be great,” Menezes said.

Together, we’re building the infrastructure for a new kind of healthcare,” said Oskowitz, closing one of the biggest gaps in digital health between suspecting a problem and getting treated, “and that’s what Simple HealthKit is doing.”

Just like its current assessment, Doctronic will assess the capability of correctly assessing the patient’s presentation and giving a correct suggestion to take forward, Oskowitz said. If all patients are attended by a human physician after the AI consultation, then it would be possible to compare the recommendations of the human physician with that of the AI, he said.

Healthcare has been fragmented and hasn’t been continuous in the past, Menezes said.

When people have a health issue, they fall through the cracks between concern and screening, or screening and treatment; it is easy for them to follow, and together, we are making that one connected journey, reflecting the innovation and new expectations of consumers in the health care space today.

HRSA data shows that over 108 million Americans reside in primary care shortage areas, which is approximately a third of the U.S. population, or 27% to 30%. Those access gaps can be closed by Simple HealthKit’s integration with Doctronic, Menezes claimed. The alliance has come at a time when the two firms are both fast-growing.

The platform has since been used by over 300,000 unique weekly users and was the first AI-native platform to gain approval to renew prescriptions in the U.S. by itself, company executives said.

Simple HealthKit continues to grow its relationships with health plans across the country, pharma companies, governments and health systems, with programs ranging from chronic conditions, cancer screening, STI testing, to enterprise programs with Amazon and Walmart.

 AI clinical care services are still expanding, with companies incorporating AI chatbots in their symptom checking, triage, and navigation services. Menezes claims the collaboration with Doctronic is “not only a partnership, but it is a new blueprint for healthcare.

Instead of leaving patients to navigate a disjointed healthcare system, we are creating one that takes them through every step, and we believe that is the future of healthcare – technology is not a replacement for care; it is making care more accessible, connected, and human.

Healthcare technology continues to evolve as Doctronic and Simple HealthKit announce a strategic collaboration designed to bridge AI-powered clinical treatment with convenient at-home diagnostic screening. The partnership aims to simplify the patient journey by combining virtual medical evaluations with reliable home testing, allowing individuals to receive timely care without unnecessary clinic visits.

As demand for digital healthcare grows, Doctronic is leveraging artificial intelligence to provide personalized clinical guidance while integrating Simple HealthKit’s home-based testing capabilities. Together, the companies hope to improve accessibility, reduce delays in diagnosis, and enhance patient outcomes.

Doctronic Expands Virtual Healthcare with Home Testing

The collaboration enables patients using Doctronic to receive AI-assisted clinical assessments and, when appropriate, order at-home screening kits from Simple HealthKit. Once samples are collected and processed, healthcare providers can review verified laboratory results and recommend suitable treatment options through the digital platform.